Katherine Waghorn
Wessex Regional Genetics Laboratory(GB)University of Southampton(GB)Salisbury NHS Foundation Trust(GB)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Eosinophilic Disorders and Syndromes, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Most-Cited Works
- → Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders(2010)1,122 cited
- → Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA–positive chronic eosinophilic leukemia(2007)204 cited
- → Durable responses to imatinib in patients with PDGFRB fusion gene–positive and BCR-ABL–negative chronic myeloproliferative disorders(2006)172 cited
- → Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms(2015)162 cited
- → Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia(2006)118 cited
- → Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha(2005)116 cited